Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Raptor Pharmaceutical Corp (NASDAQ:RPTP.DL)

CAPS Rating: No stars

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:RPTP.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

bassman87 (< 20)
Submitted November 22, 2010

Has a solid pipeline of products that should be advancing into phase 3 stage of FDA approval and beyond through the next 12 to 36 months. Most notable of all its products currently in phase 2 stage of development, is the drug Convivia. It is the only… More

zzlangerhans (99.00)
Submitted November 30, 2015

36 month data from the CYST-HD trial of DR Cysteamine for Huntington's Disease is due to drop this month and I'm not optimistic. First of all, the rationale for the trial is sketchy - induction of beneficial cellular stress responses via the… More

NASDAQ:RPTP.DL VS S&P 500 (SPY)

NASDAQ:RPTP.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about RPTP.DL.

No one has written a Pitch for RPTP.DL stock yet. Tell us why you think RPTP.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in RPTP.DL.

No players have picked RPTP.DL yet. Tell us why you think RPTP.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RPTP.DL.